Evidence map›Paper›PMID 30987410›Full record

ReviewInternational journal of molecular sciences2019

Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2.

Toshihisa Komori

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 411 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
411citing papers in PubMed, 1 pooled it
26.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

411 citing papers in PubMed, 1 synthesis or guideline pooled it, 802 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. SCFSignal transduction and targeted therapy · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. [Preparation andZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

351 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Toshihisa KomoriBasic and Translational Research Center for Hard Tissue Disease, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Japan. komorit@nagasaki-u.ac.jp.
Nagasaki University · JP

Funding

Japanese Ministry of Education, Culture, Sports, Science and Technology 18H05283
6 · The paper itself

Abstract

Runx2 is essential for osteoblast differentiation and chondrocyte maturation. During osteoblast differentiation, Runx2 is weakly expressed in uncommitted mesenchymal cells, and its expression is upregulated in preosteoblasts, reaches the maximal level in immature osteoblasts, and is down-regulated in mature osteoblasts. Runx2 enhances the proliferation of osteoblast progenitors by directly regulating

Indexed as

AnimalsCell DifferentiationCell ProliferationCore Binding Factor Alpha 1 SubunitHumansOsteoblastsCore Binding Factor Alpha 1 Subunitcleidocranial dysplasiadifferentiationFgfrhedgehogosteoblastproliferationPthr1Runx2Sp7Wnt

Identifiers

PMID30987410
PMCPMC6480215
OpenAlexW2935451440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.